
ESCMID Global 2025: Initial ABI-5366 data supports monthly dosing for genital herpes
Early clinical and preclinical findings presented at the 35th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference in Vienna, Austria, suggest that Assembly Biosciences’ ABI-5366, a novel herpes simplex virus (HSV) …